Are Dermal Fillers “MHRA-Approved”? Why the Answer Actually Matters

Haus Of Ästhetik
4 days ago
5 min read

Ask most people whether their dermal filler is “MHRA-approved” and they will usually answer with complete confidence, assuming the phrase means the same thing it does on a box of paracetamol. The truth is a little more nuanced, and it is worth understanding properly, both for your own safety and because the rules governing fillers in the UK are in the middle of changing.

This matters more than it sounds. The words on a leaflet or an Instagram caption shape how safe a patient feels about a treatment, and if those words are wrong, that sense of safety is built on a misunderstanding.

Key takeaways

Dermal fillers sit under medical device regulation in the UK, not medicines regulation, so the MHRA does not “approve” them the way it licenses a prescription drug.
A CE or UKCA mark confirms a product has met manufacturing, quality and safety standards. It is not a guarantee of how that product will perform in your face, in your practitioner's hands.
A regulatory gap currently lets some fillers marketed purely as cosmetic, rather than medical, products avoid formal device regulation altogether. The MHRA has said it intends to close this.
The training, registration and clinical governance of the person holding the needle matters at least as much as any mark printed on the packaging.

What “MHRA-approved” actually means

The Medicines and Healthcare products Regulatory Agency licenses medicines under the Human Medicines Regulations 2012. Before a medicine reaches a pharmacy shelf, its manufacturer must submit clinical trial evidence of safety, efficacy and quality, and the MHRA assesses that evidence directly before granting a licence. That is what people usually picture when they hear “approved by the MHRA”.

Dermal fillers do not go through that process, because they are not classed as medicines. They are regulated, but under a different and less familiar framework, one built around the safety of the device itself rather than a licensing decision on each specific product's clinical claims.

So what are dermal fillers, if not medicines?

Where a filler is marketed with a medical claim, most are, it falls under the Medical Devices Regulations 2002 and is treated as a Class III device, the UK's highest risk category for devices, sitting alongside things like heart valves and hip implants. That classification exists because an injectable product placed under the skin carries genuine risks: infection, vascular occlusion, granuloma formation and migration among them.

A Class III filler must be assessed by a notified body against recognised safety and manufacturing standards before it can legally be sold in the UK, and must carry a UKCA mark, or currently still a CE mark during the transition period, to prove it. The manufacturer must also register the product and maintain a UK Responsible Person accountable for it.

What UKCA and CE marking do, and do not, guarantee

A UKCA or CE mark tells you the product has been through a formal conformity assessment covering manufacturing quality, biocompatibility and basic safety data. That is genuinely reassuring information, and worth asking to see before any treatment.

It does not tell you the product is the right choice for your face, your goals or your medical history. It does not assess the skill of the person injecting it, and it says nothing about aftercare, complication management or how quickly a practitioner would recognise and treat something like vascular occlusion if it occurred. The mark is a floor, not a ceiling.

There is also a genuine gap in the current framework worth knowing about. Products marketed purely for aesthetic effect, with no medical claim attached by the manufacturer, can currently sit outside device regulation altogether. It is a legal grey area that most patients have no way of spotting from the outside.

Why the rules are about to tighten

The MHRA has confirmed it intends to expand the scope of the Medical Devices Regulations 2002 so that products marketed for aesthetic or cosmetic use, where the function and risk profile closely resemble a medical device, are captured regardless of the claims a manufacturer attaches to them. In plain terms, the aim is to close the loophole described above so that a filler is a regulated device because of what it does, not because of how it is marketed.

This sits alongside a wider push for reform. The Government has been consulting on a licensing scheme for practitioners carrying out non-surgical cosmetic procedures in England, with further work still needed through 2026 on training standards, infection control and indemnity requirements before it takes effect. Separately, the Care Quality Commission extended its regulated activities in 2025, though only narrowly, to cover the highest risk procedures such as intimate area injectables, rather than routine facial treatments.

None of this is finished business yet. But the direction of travel is clear: tighter product regulation, clearer accountability for practitioners, and less room for ambiguous marketing claims to do the reassuring that proper evidence should be doing instead.

What this actually means for you

A sensible approach is to treat the regulatory status of a product as one part of your due diligence, alongside the practitioner's own credentials, rather than as the whole answer.

Ask which specific product is being used, and ask to see evidence of its CE or UKCA marking and batch number.
Ask about the practitioner's professional registration, for example with the NMC, GMC, GDC or HCPC, and how long they have held it.
Ask whether the clinic is accredited by a recognised body such as Save Face or the JCCP, which independently verify training and standards.
Ask what happens if something goes wrong: who manages complications, what indemnity cover is in place, and how quickly you could be seen.

A practitioner who answers these questions readily, without hesitation or defensiveness, is usually telling you something true about how seriously they take clinical governance.

A few common questions, answered plainly

Does a CE or UKCA mark mean a filler is safe for me specifically? Not on its own. It confirms the product meets manufacturing and design safety standards, but suitability depends on your individual anatomy, medical history and the skill of whoever is injecting it, which is why a proper consultation matters more than a mark on a box.

Are all dermal fillers currently regulated as medical devices in the UK? Most fillers marketed with a medical claim are, and are treated as Class III devices. Some products marketed purely as cosmetic, with no medical claim, can currently sit outside that framework, which is the gap the MHRA has said it wants to close.

What is the single most useful question to ask before treatment? Ask to see the product's regulatory documentation and ask about the practitioner's professional registration. Both are reasonable requests, and a well-governed clinic will expect them.

This article is general skincare information and is not a substitute for individual medical advice. Any treatment is provided only after a personal consultation and suitability assessment. Haus of Ästhetik, Bakewell, Derbyshire.